切换至 "中华医学电子期刊资源库"
高级检索
中华妇幼临床医学杂志(电子版)

中华妇幼临床医学杂志(电子版) ›› 2022, Vol. 18 ›› Issue (02) : 220 -227. doi: 10.3877/cma.j.issn.1673-5250.2022.02.014

论著

胸腔生物电阻抗法无创血流动力学监测对新生儿脓毒症患儿心功能障碍的预测价值
张慧平, 王金会, 李思袖, 杨雪峰, 唐小晶, 张海波, 朱巧棉, 梁若冰, 孙欢, 简茹, 刘建萍†()   
  1. 西安交通大学附属儿童医院新生儿重症监护室　710003
  • 收稿日期:2021-05-20 修回日期:2022-03-08 出版日期:2022-04-01
  • 通信作者: 刘建萍

Predictive value of non-invasive hemodynamic monitoring by bioelectrical impedance analysis in neonatal sepsis complicated with cardiac dysfunction

Huiping Zhang, Jinhui Wang, Sixiu Li, Xuefeng Yang, Xiaojing Tang, Haibo Zhang, Qiaomian Zhu, Ruobing Liang, Huan Sun, Ru Jian, Jianping Liu†()   

  1. Neonatal Intensive Care Unit, Affiliated Children′s Hospital of Xi′an Jiaotong University, Xi′an 710003, Shaanxi Province, China
  • Received:2021-05-20 Revised:2022-03-08 Published:2022-04-01
  • Corresponding author: Jianping Liu
  • Supported by:
    Natural Science Basic Research Project of Shaanxi Province(2020JM-651); Program of Affiliated Children′s Hospital of Xi′an Jiaotong University(2019A01, 2017A09)
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

张慧平, 王金会, 李思袖, 杨雪峰, 唐小晶, 张海波, 朱巧棉, 梁若冰, 孙欢, 简茹, 刘建萍. 胸腔生物电阻抗法无创血流动力学监测对新生儿脓毒症患儿心功能障碍的预测价值[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(02): 220-227.

Huiping Zhang, Jinhui Wang, Sixiu Li, Xuefeng Yang, Xiaojing Tang, Haibo Zhang, Qiaomian Zhu, Ruobing Liang, Huan Sun, Ru Jian, Jianping Liu. Predictive value of non-invasive hemodynamic monitoring by bioelectrical impedance analysis in neonatal sepsis complicated with cardiac dysfunction[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2022, 18(02): 220-227.

目的

探讨胸腔生物电阻抗法无创血流动力学监测(NHM-BIA)预测新生儿脓毒症(NS)患儿心功能障碍(CD)的价值。

方法

选择2017年1月至2020年11月，西安交通大学附属儿童医院新生儿重症监护病房(NICU)收治的152例NS患儿为研究对象。采用回顾性研究方法，根据NS患儿是否并发CD，将其分为研究组(n＝53，并发CD)与对照组(n＝99，未并发CD)。对2组患儿性别、出生胎龄、出生体重、危重新生儿比例，血清N-末端脑利钠肽前体(NT-proBNP)、高敏肌钙蛋白(hs-cTn)，肌酸激酶同工酶MB(CK-MB)，心房、室内径及射血分数，以及心率、每搏输出量指数(SI)、心排血量(CO)、心指数、每搏输出量变异度(SVV)、校正流动时间(FTC)、外周血管阻力(SVR)、外周血管阻力指数(SVRI)、心肌收缩指数(ICON)、收缩时间比(STR)等NHM-BIA指标采用成组t检验、Mann-Whitney U检验与χ2检验进行统计学比较。对NS患儿并发CD的影响因素进行多因素非条件logistic回归分析。绘制NHM-BIA不同指标预测NS患儿并发CD的受试者工作特征(ROC)曲线，并计算曲线下面积(AUC)。根据约登指数最大原则，确定这些指标预测NS患儿并发CD的最佳临界值。本研究遵循的程序符合本院伦理委员会规定，通过本院伦理委员会审查，并获得批准(审批文号：20210034)。2组NS患儿性别构成比、出生胎龄、出生体重等一般临床资料比较，差异均无统计学意义(P>0.05)。

结果

①研究组患儿危重新生儿比例及血清NT-proBNP、hs-cTn水平，均显著高于对照组，并且差异均有统计学意义(P<0.05)。②研究组NS患儿心率、SVV、SVR、SVRI、STR，均显著高于对照组，而SI、心指数、FTC、ICON，均显著低于对照组，并且差异均有统计学意义(P<0.05)。③多因素非条件logistic回归分析结果显示，血清NT-proBNP、hs-cTn水平高，是NS患儿并发CD的独立危险因素(OR＝1.001、1.095，95%CI：1.000~1.001、1.047~1.146，P均<0.001)，而心指数高是NS患儿并发CD的独立保护因素(OR＝0.075，95%CI：0.022~0.253，P<0.001)。④血清NT-proBNP、hs-cTn水平与心指数及3项指标联合预测NS患儿并发CD的AUC分别为0.814(95%CI：0.734~0.894，P<0.001)，0.858(95%CI：0.784~0.931，P<0.001)，0.925(95%CI：0.784~0.931，P<0.001)，0.975(95%CI：0.942~1.000，P<0.001)。根据约登指数最大原则，血清NT-proBNP、hs-cTn水平与心指数预测NS患儿并发CD的最佳临界值依次为13 355 ng/L、74 ng/L、2.74 L/(min·m2)，此时血清NT-proBNP、hs-cTn水平与心指数及3项指标联合预测NS患儿并发CD的敏感度分别为77.4%、58.5%、84.9%、81.1%，特异度分别为73.6%、95.4%、93.1%、96.6%。

结论

NHM-BIA可有效监测NS合并CD患儿的血流动力学改变。心指数联合血清NT-proBNP、hs-cTn对NS患儿并发CD有较高预测价值。

关键词: 脓毒症, 心功能障碍, 血流动力学, 无创血流动力学监测, 胸腔生物电阻抗法, 利钠肽，脑, 肌钙蛋白, 婴儿，新生
Objective

To explore value of non-invasive hemodynamic monitoring by bioelectrical impedance analysis (NHM-BIA) in predicting neonatal sepsis (NS) complicated with cardiac dysfunction (CD).

Methods

A total of 152 children with NS who were admitted to neonatal intensive care unit (NICU) of Affiliated Children′s Hospital of Xi′an Jiaotong University from January 2017 to November 2020 were selected as research subjects. They were divided into study group (n=53, complicated with CD) and control group (n=99, without CD) according to whether they were complicated with CD or not by retrospective analysis method. The gender, gestational age at birth, weight at birth, proportion of critically ill neonates, serum N-terminal pro-brain natriuretic peptide (NT-proBNP), high sensitive cardiac troponin (hs-cTn), and creatine kinase isoenzyme MB (CK-MB), atrial and ventricular diameter and ejection fraction, as well as heart rate, stroke volume index (SI), cardiac output (CO), cardiac index, stroke volume variability (SVV), flow time of corrected (FTC), systemic vascular resistance (SVR), systemic vascular resistance index (SVRI), index of contractility (ICON), systolic time ratio (STR) of two groups were compared by independent-samples t test, Mann-Whitney U test and chi-square test. Multivariate unconditional logistic regression analysis was used to analyze the influencing factors of NS complicated with CD in neonates. Receiver operating characteristics (ROC) curves of different indexes of NHM-BIA to predict NS complicated with CD were drawn, and area under the curve (AUC) was calculated. According to principle of maximum Youden index, the best critical value of different indexes for predicting NS complicated with CD were determined. The procedures followed in this study met the standards formulated by the Ethics Review Committee of Affiliated Children′s Hospital of Xi′an Jiaotong University and has been approved by it (Approval No. 20210034). There were no significant differences in general clinical data of neonates with NS between two groups, such as gender composition ratio, gestational age and weight at birth (P>0.05).

Results

①The proportion of critically ill neonates and serum levels of NT-proBNP and hs-cTn in study group were significantly higher than those in control group, and the differences were statistically significant (P<0.05). ②Heart rate, SVV, SVR, SVRI and STR of neonates with NS in study group were significantly higher than those in control group, while SI, cardiac index, FTC, and ICON were significantly lower than those in control group, and all differences were statistically significant (P<0.05). ③Multivariate unconditional logistic regression analysis showed that high serum levels of NT-proBNP and hs-cTn were independent risk factors for NS neonates complicated with CD (OR=1.001, 1.095; 95%CI: 1.000-1.001, 1.047-1.146, all P<0.001), while high cardiac index was an independent protective factor for NS neonates complicated with CD (OR=0.075, 95%CI: 0.022-0.253, P<0.001). ④AUC of serum levels of NT-proBNP and hs-cTn, cardiac index and three indexes combined to predict of NS neonates complicated with CD were 0.814 (95%CI: 0.734-0.894, P<0.001), 0.858 (95%CI: 0.784-0.931, P<0.001), 0.925 (95%CI: 0.784-0.931, P<0.001), and 0.975 (95%CI: 0.942-1.000, P<0.001), respectively. According to principle of maximum Youden index, the best critical values of serum levels of NT-proBNP and hs-cTn and cardiac index for predicting CD in neonates with NS were 13 355 ng/L, 74 ng/L, and 2.74 L/(min·m2), the sensitivities of serum levels of NT-proBNP and hs-cTn, cardiac index and three indexes combined were 77.4%, 58.5%, 84.9%, and 81.1%, respectively, and the specificities were 73.6%, 95.4%, 93.1%, and 96.6%, respectively.

Conclusions

NHM-BIA can effectively monitor hemodynamic changes in neonates with NS complicated with CD. Cardiac index combined with serum levels of NT-proBNP and hs-cTn has high predictive value in NS neonates complicated with CD.

Key words: Sepsis, Cardiac dysfunction, Hemodynamics, Non-invasive hemodynamic monitoring, Bioelectrical impedance analysis, Natriuretic peptide, brain, Troponin, Infant, newborn
表1 2组NS患儿相关临床资料比较
组别 例数 性别[例数(%)] 出生胎龄(周，±s) 出生体重(kg，±s) 危重新生儿[例数(%)] WBC[×109/L，M(P25~P75)] PLT[×109/L，M(P25~P75)] 血清CRP[×109/L，M(P25~P75)]
男 女
研究组 53 39(73.6) 14(26.4) 35.7±1.1 2.52±0.64 50(94.3) 7.4(7.1~8.1) 188.0(118.4~237.6) 6.7(3.6~21.5)
对照组 99 60(60.6) 39(39.4) 35.4±1.2 2.54±0.81 60(60.6) 7.5(7.2~8.2) 195.0(123.6~284.2) 6.8(2.7~22.4)
检验值   χ2＝2.560 t＝-0.147 t＝-0.448 χ2＝6.216 Z＝-0.320 Z＝-0.883 Z＝-0.253
P值   0.110 0.883 0.655 0.013 0.749 0.377 0.800
组别 例数 血清hs-cTn(ng/L，±s) 血清NT-proBNP(ng/L，±s) 血清CK-MB(mmol/L，±s) UCG(±s)
左心室内径(mm) 左心房内径(mm) 右心室内径(mm) 右心房内径(mm) 射血分数(%)
研究组 53 74.5±27.3 12 234.0±4 894.1 142.7±35.2 13.7±2.3 10.1±1.6 8.8±2.3 14.45±3.05 60.5±9.3
对照组 99 40.8±13.3 7 969.0±2 777.8 137.4±31.6 14.4±2.7 10.8±1.9 8.6±1.8 15.05±2.36 66.6±3.7
检验值   t＝9.522 t＝8.011 t＝1.558 t＝1.392 t＝1.416 t＝1.039 t＝0.801 t＝0.637
P值   <0.001 <0.001 0.122 0.167 0.160 0.301 0.425 0.525
表2 2组NS患儿NHM-BIA指标比较(±s)
组别 例数 心率(次/min) SI[L/(min·m2)] 心指数[L/(min·m2)] SVV(%) FTC(ms) SVR(dyn·s/cm5) SVRI[dyn·s/(cm5·m2)] ICON STR
研究组 53 150.5±18.9 16.7±2.3 2.4±0.6 26.7±3.3 168.6±23.0 8 237.2±725.4 1 938.5±274.9 52.7±9.2 0.67±0.16
对照组 99 144.1±16.3 24.7±2.3 3.6±0.7 15.8±2.3 248.5±23.3 6 463.4±536.3 1 145.6±227.6 74.8±14.4 0.46±0.09
t值   2.140 -19.158 -10.198 22.917 -19.799 10.452 18.457 -10.450 13.897
P值   0.034 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
表3 NS患儿并发CD影响因素的多因素非条件logistic回归分析结果
影响因素 B SE Wald值 P值 OR值 OR值95%CI
血清NT-proBNP水平 <0.001 <0.001 13.582 <0.001 1.001 1.000~1.001
血清hs-cTn水平 0.091 0.023 15.458 <0.001 1.095 1.047~1.146
心指数 -2.592 0.621 17.417 <0.001 0.075 0.022~0.253
心率 0.035 0.021 2.661 0.103 1.036 0.993~1.080
SI -0.376 0.335 1.261 0.262 0.687 0.356~1.324
SVV -0.702 1.508 0.217 0.642 0.496 0.026~9.517
FTC 5.257 9.977 0.278 0.598 19.811 0.001~5.960
SVR 2.826 2.145 1.735 0.188 16.872 0.252~11.32
SVRI -0.015 0.026 0.323 0.570 0.985 0.936~1.037
ICON -0.002 0.011 0.039 0.843 0.998 0.976~1.020
STR -1.537 3.054 0.253 0.615 0.215 0.001~54.321
常数项 -6.244 3.512 3.162 0.075 0.002 —
图1 血清NT-proBNP、hs-cTn水平与心指数及3项指标联合预测NS患儿并发CD的ROC曲线注：NT-proBNP为脑利钠肽前体，hs-cTn为高敏肌钙蛋白，NS为新生儿脓毒症，CD为心功能障碍。ROC曲线为受试者工作特征曲线
表4 血清NT-proBNP、hs-cTn水平与心指数及3项指标联合预测NS患儿并发CD的ROC曲线分析结果
指标 AUC AUC 95%CI P值 最佳临界值 敏感度(%) 特异度(%) 约登指数
血清NT-proBNP水平(ng/L) 0.814 0.734~0.894 <0.001 13 355 77.4 73.6 0.510
血清hs-cTn水平(ng/L) 0.858 0.784~0.931 <0.001 74 58.5 95.4 0.539
心指数[L/(min·m2)] 0.925 0.877~0.973 <0.001 2.74 84.9 93.1 0.780
上述3项指标联合 0.975 0.942~1.000 <0.001 — 81.1 96.6 0.777
[1]
Bedi N, Kumar CM, Gupta P. 50 years ago in the journal of pediatrics: neonatal septicemia[J]. J Pediatr, 2020, 216: 135-142. DOI: 10.1016/j.jpeds.2019.07.070.
[2]
Rossi Neto JM. Continuous non-invasive cardiac output: myth or reality[J]. Arq Bras Cardiol, 2019, 113(2): 240-241. DOI: 10.5935/abc.20190163.
[3]
O′Neill R, Dempsey EM, Garvey AA, et al. Non-invasive cardiac output monitoring in neonates[J]. Front Pediatr, 2021, 8: 614585. DOI: 10.3389/fped.2020.614585.
[4]
中华医学会儿科学分会新生儿学组，中国医师协会新生儿科医师分会感染专业委员会. 新生儿败血症诊断及治疗专家共识(2019年版)[J]. 中华儿科杂志，2019, 57(4): 252-257. DOI: 10.3760/cma.j.issn.0578-1310.2019.04.005.
[5]
邵肖梅，叶鸿瑁，丘小汕．实用新生儿学[M]. 5版. 北京：人民卫生出版社，2019: 575-578.
[6]
秦嫣然，白科，刘成军，等. 应用血管活性药物评分评估完全性肺静脉异位引流患儿术后早期死亡风险[J]. 中国循环杂志，2020，35(12)：1223-1228. DOI: 10.3969/j.issn.1000-3614.2020.12.011.
[7]
曲雯雯，吴珺，黑明燕. 新生儿转运评分的应用进展[J]. 中华新生儿科杂志，2022，37(02): 187-189. DOI：10.19435/j.1672-1721.2021.27.060
[8]
McCarthy KN, Pavel A, Garvey AA, et al. Feasibility of non-invasive cardiac output monitoring at birth using electrical bioreactance in term infants[J]. Arch Dis Child Fetal Neonatal Ed, 2021, 106(4): 431-434. DOI: 10.1136/archdischild-2019-318244.
[9]
McGovern M, Miletin J. Cardiac output monitoring in preterm infants[J]. Front Pediatr, 2018, 6: 84-90. DOI: 10.3389/fped.2018.00084.
[10]
Grollmuss O, Demontoux S, Capderou A, et al. Electrical velocimetry as a tool for measuring cardiac output in small infants after heart surgery[J]. Intensive Care Med, 2012, 38(6): 1032-1039. DOI: 10.1007/s00134-012-2530-3.
[11]
Grollmuss O, Gonzalez P. Non-invasive cardiac output measurement in low and very low birth weight infants: a method comparison[J]. Front Pediatr, 2014, 2: 16-23. DOI: 10.3389/fped.2014.00016.
[12]
Monnet X, Vaquer S, Anguel N, et al. Comparison of pulse contour analysis by pulsioflex and vigileo to measure and track changes of cardiac output in critically ill patients[J]. Br J Anaesth, 2015, 114(2): 235-243. DOI: 10.1093/bja/aeu375.
[13]
Squara P, Rotcajg D, Denjean D, et al. Comparison of monitoring performance of bioreactance vs. pulse contour during lung recruitment maneuvers[J]. Crit Care, 2009, 13(4): R125. DOI: 10.1186/cc7981.
[14]
桑田，王颖，冯雪，等. 生物电抗无创心排量监测在儿童中的应用初探[J]. 中国小儿急救医学，2016，23(2): 78-81. DOI: 10.3760/cma.j.issn.1673-4912.2016.02.002.
[15]
Rali AS, Buechler T, Van Gotten B, et al. Non-invasive cardiac output monitoring in cardiogenic shock: the NICOM study[J]. J Card Fail, 2020, 26(2): 160-165. DOI: 10.1016/j.cardfail.2019.11.015.
[16]
李清涛，陈红云，田利远. 血清生长分化因子-15、心脏型脂肪酸结合蛋白及脑利钠肽水平与肺炎合并心力衰竭患儿预后的关系[J/OL]. 中华妇幼临床医学杂志(电子版), 2019, 15(6): 688-694. DOI: 10.3877/cma.j.issn.1673-5250.2019.06.013.
[17]
陈强，赵海燕，訾慧芬. BNP及NT-proBNP在小儿心力衰竭诊断中的应用[J/OL]. 中华妇幼临床医学杂志(电子版), 2014, 10(1): 120-122. DOI: 10.3877/cma.j.issn.1673-5250.2014.01.030.
[18]
呼邦传，王宇佳，葛伟东，等. 血浆B型脑利钠肽联合左室舒张功能障碍对脓毒症休克患者预后的评估[J]．中华医学杂志，2016, 96(29): 2295-2300. DOI: 10.3760/cma.j.issn.0376-2491.2016.29.003.
[19]
张乾忠，祝华. 儿童心肌损伤及心肌炎诊治中的几个临床热点问题[J]. 中国小儿急救医学，2018, 25(9): 641-646. DOI: 10.3760/cma.j.issn.1673-4912.2018.09.001.
[20]
McGregor D, Sharma S, Gupta S, et al. Emergency department non-invasive cardiac output study (EDNICO): an accuracy study[J]. Scand J Trauma Resusc Emerg Med, 2020, 28(1): 8-17. DOI: 10.1186/s13049-020-0704-5.
[1] 魏淑婕, 惠品晶, 丁亚芳, 张白, 颜燕红, 周鹏, 黄亚波. 单侧颈内动脉闭塞患者行颞浅动脉-大脑中动脉搭桥术的脑血流动力学评估[J]. 中华医学超声杂志（电子版）, 2023, 20(10): 1046-1055.
[2] 孟建标, 张庚, 焦燕娜. 脓毒症合并心功能障碍患者早期肠道微生态改变的探讨[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 279-285.
[3] 陈宇, 冯芳, 张露, 刘健. 基于生物信息学分析筛选脓毒症心肌病关键致病基因[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 286-291.
[4] 张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[5] 董晓燕, 赵琪, 唐军, 张莉, 杨晓燕, 李姣. 奥密克戎变异株感染所致新型冠状病毒感染疾病新生儿的临床特征分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 595-603.
[6] 魏徐, 张鸽, 伍金林. 新生儿脓毒症相关性凝血病的监测和治疗[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 379-386.
[7] 杨莹, 刘艳, 王央丹. 新生儿结节性硬化症相关性癫痫1例并文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 464-472.
[8] 姚咏明. 如何精准评估烧伤脓毒症患者免疫状态[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 552-552.
[9] 李凤仪, 李若凡, 高旭, 张超凡. 目标导向液体干预对老年胃肠道肿瘤患者术后血流动力学、胃肠功能恢复的影响[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 29-32.
[10] 李晓玉, 江庆, 汤海琴, 罗静枝. 围手术期综合管理对胆总管结石并急性胆管炎患者ERCP +LC术后心肌损伤的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 57-60.
[11] 窦上文, 邓欢, 刘邦锋, 岳高远志, 朱华财, 刘永达. 术前复查尿培养在预测微通道经皮肾镜取石术相关感染并发症中的作用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 361-366.
[12] 李伟, 卓剑, 黄川, 黄有攀. Lac、HO-1、sRAGE、CRP/ALB表达及脓毒症并发ARDS危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 514-516.
[13] 苗软昕, 乔晞. Toll样受体在脓毒症性急性肾损伤中的作用[J]. 中华肾病研究电子杂志, 2023, 12(04): 210-214.
[14] 谭睿, 王晶, 於江泉, 郑瑞强. 脓毒症中高密度脂蛋白、载脂蛋白A-I和血清淀粉样蛋白A的作用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(06): 749-753.
[15] 蔡荇, 郑瑞强. 肝素结合蛋白在脓毒症中的应用及研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(04): 487-490.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号